Back
62
3
Also listed as
DQJCF
OTC
Day Range
$12.17
$12.80
52-Week Range
$9.49
$15.98
Volume
16,530
50D / 200D Avg
$12.45
/
$12.95
Prev Close
$12.17
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.2 | 10.4 |
| P/B | 0.0 | 1.2 |
| ROE % | 15.8 | 12.6 |
| Net Margin % | 4.0 | 5.3 |
| Rev Growth 5Y % | 7.1 | 5.5 |
| D/E | 0.7 | 0.6 |
Key Takeaways
Revenue grew 7.08% annually over 5 years — modest growth
ROE of 15.80% — decent returns on equity
Generating 79.84B in free cash flow
P/E of 0.20 — trading at a low valuation
PEG of 0.13 suggests growth is underpriced
Cash machine — converts 88.20% of earnings into free cash flow
Growth
Revenue Growth (5Y)
7.08%
Revenue (1Y)7.24%
Earnings (1Y)2.04%
FCF Growth (3Y)0.92%
Quality
Return on Equity
15.80%
ROIC11.59%
Net Margin4.03%
Op. Margin7.22%
Safety
Debt / Equity
0.73
Current Ratio1.20
Interest Coverage25.35
Valuation
P/E Ratio
0.20
P/B Ratio0.03
EV/EBITDA1.78
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7.24% | Revenue Growth (3Y) | 7.71% |
| Earnings Growth (1Y) | 2.04% | Earnings Growth (3Y) | 16.96% |
| Revenue Growth (5Y) | 7.08% | Earnings Growth (5Y) | 13.92% |
| Profitability | |||
| Revenue (TTM) | 2.25T | Net Income (TTM) | 90.51B |
| ROE | 15.80% | ROA | 5.99% |
| Gross Margin | 31.90% | Operating Margin | 7.22% |
| Net Margin | 4.03% | Free Cash Flow (TTM) | 79.84B |
| ROIC | 11.59% | FCF Growth (3Y) | 0.92% |
| Safety | |||
| Debt / Equity | 0.73 | Current Ratio | 1.20 |
| Interest Coverage | 25.35 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 0.20 | P/B Ratio | 0.03 |
| P/S Ratio | 0.01 | PEG Ratio | 0.13 |
| EV/EBITDA | 1.78 | Dividend Yield | 0.02% |
| Market Cap | 18.51B | Enterprise Value | 289.14B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.25T | 2.10T | 1.94T | 1.83T | 1.71T |
| Net Income | 90.51B | 88.70B | 66.17B | 61.93B | 53.73B |
| EPS (Diluted) | 60.38 | 29.62 | 22.13 | 20.48 | 16.90 |
| Gross Profit | 716.73B | 662.90B | 600.39B | 543.39B | 497.32B |
| Operating Income | 162.30B | 140.19B | 105.26B | 88.69B | 81.31B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.51T | 1.50T | 1.48T | 1.38T | 1.37T |
| Total Liabilities | 886.98B | 951.41B | 1.02T | 984.43B | 931.49B |
| Shareholders' Equity | 607.84B | 537.94B | 454.03B | 392.49B | 418.88B |
| Total Debt | 442.59B | 500.70B | 612.72B | 614.37B | 555.63B |
| Cash & Equivalents | 171.96B | 172.72B | 242.09B | 176.78B | 157.52B |
| Current Assets | 527.99B | 513.43B | 551.84B | 486.53B | 495.50B |
| Current Liabilities | 441.59B | 419.22B | 368.42B | 326.38B | 353.55B |
Strategy Scores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#189 of 1024
#633 of 658
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026